The 2025 Weill Cornell Medicine Biomedical Innovation Conference brings together academic founders with investors, industry representatives, entrepreneurs and ecosystem partners with the expressed goal of finding opportunities to connect and collaborate. The conference is a rare opportunity to meet a diverse group of life science inventors and spinout companies across therapeutics, device, digital health and diagnostic sectors. All Weill Cornell Medicine-affiliated inventors are encouraged to participate. In addition, select startup companies from the Upper East Side ecosystem, including Rockefeller University, Memorial Sloan Kettering, and surrounding hospitals, as well as startups where faculty serve as CMOs and Scientific Advisors, are also in attendance.
Over the years, this event has been a proven catalyst for direct investment from early-stage investors, co-development relationships with industry, and introductions to experienced management teams. Please contact Loren Busby (lob4002@med.cornell.edu) for more information.